Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2012
05/16/2012CN102458441A 用于治疗神经疾病的模型系统和治疗方案 For the treatment of neurological disease model systems and treatment regimens
05/16/2012CN102458428A Nfat signal inhibitor and calcineurin inhibitor
05/16/2012CN102458425A Regeneration and repair of neural tissue following injury
05/16/2012CN102458414A Use of toosendanin or melia azedarach extracts for preventing or treating dementia
05/16/2012CN102458407A Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
05/16/2012CN102458406A Oral liquid preparation
05/16/2012CN102458397A Pharmaceutical composition comprising rotigotine salts (acid or na), especially for iontophoresis
05/16/2012CN102458395A Neurite elongation agent, memory-improving agent and anti-alzheimer agent comprising 4'-demethylnobiletin or 4'-demethyltangeretin as active ingredient, and process for production of the compound
05/16/2012CN102458387A New compositions for treating cmt and related disorders
05/16/2012CN102453661A Formula of health-care wine and making method thereof
05/16/2012CN102453080A Modified small peptide and application thereof
05/16/2012CN102453074A Pentacyclic triterpene saponin and application thereof
05/16/2012CN102452951A Agomelatine and pharmaceutical composition thereof
05/16/2012CN102451465A Use of SIRT1 in preparation of drugs for prevention of diseases caused by endothelial dysfunction
05/16/2012CN102451463A Naja naja atra analgesic peptide transdermal preparation
05/16/2012CN102451460A Recipe of foot immersing liquid for relieving fatigue
05/16/2012CN102451456A Preparation method of Chinese medicinal prescription for treating hyperhidrosis
05/16/2012CN102451443A Recipe for treating gynecological inflammation and preparation process of recipe
05/16/2012CN102451442A Extraction process of anti-depression Chinese medicament
05/16/2012CN102451430A Preparation method for medicine scattered niter used for treating headache
05/16/2012CN102451390A Traditional Chinese medicine formula for treating insomnia
05/16/2012CN102451385A Chinese medicinal formula for treating Meniere's syndrome
05/16/2012CN102451383A Neuralgia treating capsule
05/16/2012CN102451299A Traditional Chinese medicine for treating cold
05/16/2012CN102451248A Application of traditional Chinese medicine composition in preparation of medicament for treating diabetic neuropathy
05/16/2012CN102451228A Preparation method and application of antibacterial and antiviral elsholtzia densa benth volatile oil
05/16/2012CN102451225A Production method of health care capsule capable of nourishing stomach and sobering
05/16/2012CN102451215A Extraction technology of gypenoside
05/16/2012CN102451209A Application of Chinese medicine composition to preparation of medicines for neuroprotection after spinal cord injury
05/16/2012CN102451206A Quality control method of acanthopanax root and antler blood oral liquid
05/16/2012CN102451201A Extraction process for ginkgo leaf extract for injection
05/16/2012CN102451194A Extraction method for scorpion venom
05/16/2012CN102451186A Preparation method of cinnabar powder
05/16/2012CN102451179A Enteric solid preparation containing lycopene, resveratrol or melatonin and preparation method of enteric solid preparation
05/16/2012CN102451174A Application of protocatechualdehyde to preparation of medicaments for treating human neurodegenerative diseases
05/16/2012CN102451172A Transdermal patch for relieving pain, and preparation method thereof
05/16/2012CN102451166A Setron medicament oral cavity disintegrating tablet and preparation method thereof
05/16/2012CN102451165A Rotundine orally disintegrating tablets and preparation method thereof
05/16/2012CN102451164A Analgesic oral cavity disintegrating tablet and preparation method thereof
05/16/2012CN102451162A Olanzapine medicine absorbed through oral mucosa
05/16/2012CN102451133A Degradable facial mask with sleeping function and preparation method thereof
05/16/2012CN102451129A Chinese medicinal shampoo with sleeping function and preparation method thereof
05/16/2012CN102450890A Method for manufacturing healthcare photo frame
05/16/2012CN101818150B Neurogenesis
05/16/2012CN101804108B Traditional Chinese medicine composition for treating neurogenic headache
05/16/2012CN101574507B Nasal administration system for treating headache
05/16/2012CN101500567B Use of a p38 kinase inhibitor for treating psychiatric disorders
05/16/2012CN101370780B Organic compound of aripiprazole
05/16/2012CN101282936B Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
05/15/2012US8178713 Sulfur-containing phospholipid derivatives
05/15/2012US8178674 Process for the preparation of ziprasidone
05/15/2012US8178651 Somatostatin-dopamine chimeric analogs
05/15/2012US8178574 Tosylate salt of trans-N-isobutyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-yl-methyl)-phenyl] cyclobut anecarboxamide
05/15/2012US8178489 Formulation for aviptadil
05/15/2012US8178089 Neuronal progenitors from feeder-free human embryonic stem cell culture
05/15/2012CA2694480C Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
05/15/2012CA2650297C Hydroxymatairesinol in cancer prevention
05/15/2012CA2558782C Association between agomelatine and a noradrenaline recapture inhibitor and the pharmaceutical compositions that contain it
05/15/2012CA2526361C Amide derivative
05/15/2012CA2518591C Use of pyridin-2-yl-methylamine derivatives to prepare a medicine for treating symptoms of chronic pain of neuropathic or psychogenic origin
05/15/2012CA2517893C Use as medications of cholest-4-en-3-one derivatives, pharmaceutical compounds containing them, new derivatives and their preparation process
05/15/2012CA2477593C Chemical igf-i formulation for the treatment and prevention of neurodegenerative diseases
05/15/2012CA2470863C Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
05/15/2012CA2470500C Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
05/15/2012CA2464471C Method of treating depression with delta receptor agonist compounds
05/15/2012CA2463569C Activator for peroxisome proliferator-activated receptor .delta.
05/15/2012CA2378243C Methods for treating or preventing pain and anxiety
05/15/2012CA2283642C Therapeutic compositions
05/10/2012WO2012061828A2 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
05/10/2012WO2012061289A2 Methods for treatment of brain injury utilizing biologics
05/10/2012WO2012061062A1 Use of teriflunomide for improving motor function
05/10/2012WO2012061060A1 Use of teriflunomide for treating brain atrophy
05/10/2012WO2012060517A1 Pharmaceutical composition for prevention and treatment of neurologic disorders containing cd45-expressed mesenchymal stem cells as active ingredient
05/10/2012WO2012060396A1 Trans-2-decenoic acid derivative and medicament containing same
05/10/2012WO2012059920A1 Ladostigil dosage regime
05/10/2012WO2012059869A1 Gpr17-modulating compounds, diagnostic and therapeutic uses thereof
05/10/2012WO2012059815A1 Accordion pill comprising levodopa for an improved treatment of parkinson's disease symptoms
05/10/2012WO2012059541A1 Novel treatment of multiple sclerosis (ms)
05/10/2012WO2012059482A1 Use of active pharmaceutical compounds for the treatment of central nervous system conditions
05/10/2012WO2012059443A2 Novel neurotrypsin inhibitors
05/10/2012WO2012059442A2 Neurotrypsin inhibitors
05/10/2012WO2012059432A1 N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
05/10/2012WO2012059431A1 Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
05/10/2012WO2012059371A1 Dihydrooxazol-2-amine derivatives
05/10/2012WO2012059171A1 7-([1,2,3]triazol-4-yl)-pyrrolo[2,3-b]pyrazine derivatives
05/10/2012WO2012059001A1 Imidazole derivatives and preparation method and use thereof
05/10/2012WO2012019428A8 Benzohydrol derivatives, a preparation process and pharmaceutical use thereof
05/10/2012WO2012016081A3 Method and therapeutic for the treatment and regulation of memory formation
05/10/2012WO2012012656A3 Materials and methods for treating neurodegenerative diseases
05/10/2012WO2012012347A3 Methods of intravenous administration of glyburide and other drugs
05/10/2012WO2012007658A4 Use of the pat nonapeptide in treating and preventing neurodegenerative diseases
05/10/2012WO2011156331A3 Human neural progenitor derived dopaminergic progenitors and neurons
05/10/2012WO2011146589A3 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles
05/10/2012WO2011031818A3 Histamine h3 inverse agonists and antagonists and methods of use thereof
05/10/2012US20120116059 Treatment For M Treatment For Multiple Sclerosis
05/10/2012US20120115950 Abuse-resistant amphetamine prodrugs
05/10/2012US20120115943 Composition and method for neuroprotection against excitotoxic injury
05/10/2012US20120115928 Mirna and its targets respectively the proteins made based on the targets as a prognostic, diagnostic biomarker and therapeutic agent for cancer
05/10/2012US20120115927 Pharmaceutical agent for preventing cell death
05/10/2012US20120115919 Methods of treating and preventing/reducing the likelihood of mesial temporal lobe epilepsy (tle)
1 ... 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 ... 1833